Parabilis Medicines, Inc. (PBLS)
Fog Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane in 2015 and is headquartered in Cambridge, MA.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Parabilis Medicines, Inc.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
based on 123.53M shares outstanding
USFog Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company.
It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them.
The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane in 2015 and is headquartered in Cambridge, MA.
Leadership
Mathai Mammen
CEO, President, Treasurer & Chairman
Teresa L. Jurgensen
Executive VP, Secretary & General Counsel
Fawzi Benzaghou
Chief Medical Officer
Jianing Di
VP of International R&D and Corporate Development
Employees
145
Country
US
Sector
Healthcare
Website
parabilismed.com
| Insider | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
 Tendler Craig | Director | Grant/Award | 20.3K | -- | Aug 22, 2026 |
 RA CAPITAL MANAGEMENT, L.P. | Director | Purchase | 47.3K | $1.41M | Jul 22, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | Director | Purchase | 6.5K | $189.7K | Jul 21, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | Director | Purchase | 37.7K | $1.13M | Jul 21, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | Director | Purchase | 21.7K | $606.6K | Jul 21, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | Director | Purchase | 98.4K | $2.67M | Jul 20, 2026 |
| Name | Shares | % | Source |
|---|---|---|---|
RA CAPITAL MANAGEMENT, L.P. | 28.9M | 23.4% | 13F |
FMR LLC | 10.3M | 8.3% | 13F |
ARCH Venture Management, LLC | 6.4M | 5.2% | 13F |
venBio Partners LLC | 5.3M | 4.3% | 13F |
Alphabet Inc. | 4.9M | 4.0% | 13F |
Nextech Invest Ltd. | 4.7M | 3.8% | 13F |
Cormorant Asset Management, LP | 4.6M | 3.7% | 13F |
REGENERON PHARMACEUTICALS, INC. | 4.2M | 3.4% | 13F |
Siren, L.L.C. | 3.0M | 2.4% | 13F |
FARALLON CAPITAL MANAGEMENT, L.L.C. | 2.4M | 1.9% | 13F |
Insiders
- Tendler CraigDirector
- RA CAPITAL MANAGEMENT, L.P.Director
- SEBULSKY ALANDirector
- FITZGERALD EDWARD MDirector
- Borisy AlexisDirector
- Levy Guy10% Owner
- Flynn James E10% Owner
- Yeshwant KrishnaDirector
- Weber BarbaraDirector
- Simson JakeDirector
based on 123.53M shares outstanding
US30d Avg
1.08M
60d Avg
1.09M
90d Avg
834.82K